Perkins Coie Trust Company’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.76M | Sell |
18,907
-247
| -1% | -$53.1K | 0.79% | 34 |
|
|
2026
Q1 | $4.17M | Sell |
19,154
-313
| -2% | -$69.4K | 0.8% | 36 |
|
|
2025
Q4 | $4.45M | Sell |
19,467
-659
| -3% | -$150K | 0.83% | 33 |
|
|
2025
Q3 | $4.66M | Buy |
20,126
+705
| +4% | +$144K | 0.88% | 32 |
|
|
2025
Q2 | $3.6M | Sell |
19,421
-257
| -1% | -$47.8K | 0.61% | 44 |
|
|
2025
Q1 | $4.12M | Sell |
19,678
-582
| -3% | -$113K | 0.94% | 35 |
|
|
2024
Q4 | $3.6M | Sell |
20,260
-375
| -2% | -$68.9K | 0.79% | 41 |
|
|
2024
Q3 | $4.07M | Sell |
20,635
-179
| -0.9% | -$33.4K | 0.9% | 37 |
|
|
2024
Q2 | $3.57M | Sell |
20,814
-2,822
| -12% | -$467K | 0.83% | 40 |
|
|
2024
Q1 | $4.3M | Sell |
23,636
-831
| -3% | -$143K | 1.01% | 34 |
|
|
2023
Q4 | $3.79M | Sell |
24,467
-1,448
| -6% | -$211K | 0.96% | 34 |
|
|
2023
Q3 | $3.86M | Sell |
25,915
-327
| -1% | -$48K | 1.09% | 28 |
|
|
2023
Q2 | $3.54M | Sell |
26,242
-827
| -3% | -$121K | 1% | 33 |
|
|
2023
Q1 | $4.31M | Buy |
27,069
+595
| +2% | +$91K | 1.29% | 25 |
|
|
2022
Q4 | $4.28M | Sell |
26,474
-605
| -2% | -$92.8K | 1.37% | 24 |
|
|
2022
Q3 | $3.63M | Buy |
27,079
+144
| +0.5% | +$20.7K | 1.39% | 26 |
|
|
2022
Q2 | $4.13M | Sell |
26,935
-188
| -0.7% | -$28.7K | 1.5% | 22 |
|
|
2022
Q1 | $4.4M | Sell |
27,123
-106
| -0.4% | -$15.4K | 1.37% | 29 |
|
|
2021
Q4 | $3.69M | Buy |
27,229
+1,373
| +5% | +$162K | 1.08% | 37 |
|
|
2021
Q3 | $2.79M | Sell |
25,856
-85
| -0.3% | -$9.71K | 0.87% | 44 |
|
|
2021
Q2 | $2.92M | Buy |
25,941
+18
| +0.1% | +$2.03K | 0.9% | 44 |
|
|
2021
Q1 | $2.81M | Sell |
25,923
-769
| -3% | -$82.3K | 0.93% | 44 |
|
|
2020
Q4 | $2.86M | Buy |
26,692
+506
| +2% | +$48.6K | 0.98% | 40 |
|
|
2020
Q3 | $2.29M | Buy |
26,186
+20
| +0.1% | +$1.88K | 0.92% | 41 |
|
|
2020
Q2 | $2.57M | Buy |
26,166
+1,219
| +5% | +$107K | 1.06% | 35 |
|
|
2020
Q1 | $1.9M | Buy |
24,947
+720
| +3% | +$61.3K | 0.97% | 44 |
|
|
2019
Q4 | $2.15M | Buy |
24,227
+1,800
| +8% | +$149K | 0.88% | 49 |
|
|
2019
Q3 | $1.7M | Buy |
22,427
+167
| +0.8% | +$11.4K | 0.75% | 53 |
|
|
2019
Q2 | $1.62M | Sell |
22,260
-161
| -0.7% | -$12.7K | 0.74% | 53 |
|
|
2019
Q1 | $1.81M | Buy |
22,421
+794
| +4% | +$65K | 0.84% | 48 |
|
|
2018
Q4 | $1.99M | Sell |
21,627
-414
| -2% | -$36.4K | 1.04% | 36 |
|
|
2018
Q3 | $2.08M | Sell |
22,041
-319
| -1% | -$30.3K | 0.97% | 40 |
|
|
2018
Q2 | $2.07M | Sell |
22,360
-219
| -1% | -$21.4K | 1.02% | 39 |
|
|
2018
Q1 | $2.14M | Sell |
22,579
-639
| -3% | -$70.2K | 1.06% | 37 |
|
|
2017
Q4 | $2.25M | Sell |
23,218
-749
| -3% | -$70.6K | 1.12% | 33 |
|
|
2017
Q3 | $2.13M | Buy |
23,967
+12
| +0.1% | +$913 | 1.11% | 35 |
|
|
2017
Q2 | $1.74M | Buy |
23,955
+1,588
| +7% | +$107K | 0.93% | 41 |
|
|
2017
Q1 | $1.46M | Sell |
22,367
-96
| -0.4% | -$6.04K | 0.86% | 44 |
|
|
2016
Q4 | $1.41M | Sell |
22,463
-262
| -1% | -$16K | 0.85% | 48 |
|
|
2016
Q3 | $1.43M | Buy |
22,725
+758
| +3% | +$49.1K | 0.91% | 46 |
|
|
2016
Q2 | $1.36M | Buy |
21,967
+673
| +3% | +$41K | 0.9% | 45 |
|
|
2016
Q1 | $1.22M | Sell |
21,294
-1,343
| -6% | -$74.9K | 0.83% | 49 |
|
|
2015
Q4 | $1.34M | Buy |
22,637
+316
| +1% | +$18.2K | 1.01% | 42 |
|
|
2015
Q3 | $1.21M | Sell |
22,321
-62
| -0.3% | -$4.04K | 0.98% | 42 |
|
|
2015
Q2 | $1.5M | Buy |
22,383
+239
| +1% | +$15.6K | 1.13% | 38 |
|
|
2015
Q1 | $1.3M | Sell |
22,144
-639
| -3% | -$38.6K | 1% | 43 |
|
|
2014
Q4 | $1.49M | Sell |
22,783
-178
| -0.8% | -$11.2K | 1.19% | 38 |
|
|
2014
Q3 | $1.33M | Buy |
22,961
+113
| +0.5% | +$6.27K | 1.11% | 43 |
|
|
2014
Q2 | $1.29M | Sell |
22,848
-17
| -0.1% | -$892 | 1.2% | 46 |
|
|
2014
Q1 | $1.18M | Buy |
22,865
+447
| +2% | +$22.6K | 1.13% | 46 |
|
|
2013
Q4 | $1.18M | Buy |
+22,418
| New | +$1.1M | 1.17% | 47 |
|
Other funds holding ABBV
LMFP
ATO
HCM
AAMU
FWCM
Perkins Coie Trust Company's ABBV Position: Q2 2026 in Review
Perkins Coie Trust Company reduced its AbbVie (ABBV) stake by 1.3% in Q2 2026, selling an estimated $53.1K and leaving 18,907 shares worth $4.76M. The position accounts for 0.79% of the portfolio, ranked #34.
Perkins Coie Trust Company first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Perkins Coie Trust Company held 18,907 shares of AbbVie worth $4.76M as of Q2 2026.
- Perkins Coie Trust Company sold 247 AbbVie shares in Q2 2026, an estimated $53.1K.
- AbbVie made up 0.79% of Perkins Coie Trust Company's portfolio in Q2 2026, its #34 holding.
- Perkins Coie Trust Company first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
- 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Perkins Coie Trust Company's 13F filing for Q2 2026, filed 9 Jul 2026.